{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04877522",
            "orgStudyIdInfo": {
                "id": "CABL001A2001B"
            },
            "secondaryIdInfos": [
                {
                    "id": "2021-000602-17",
                    "type": "EUDRACT_NUMBER"
                },
                {
                    "id": "2023-507557-16-00",
                    "type": "OTHER",
                    "domain": "EU CTIS"
                }
            ],
            "organization": {
                "fullName": "Novartis",
                "class": "INDUSTRY"
            },
            "briefTitle": "Asciminib Roll-over Study",
            "officialTitle": "An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From Continued Treatment",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "asciminib-roll-over-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2030-08-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-08-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-05-04",
            "studyFirstSubmitQcDate": "2021-05-04",
            "studyFirstPostDateStruct": {
                "date": "2021-05-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Novartis Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment",
            "detailedDescription": "This is an open-label, multi-center, global roll-over study designed to assess long term safety and provide continued treatment to participants who have previously participated in an asciminib Novartis sponsored study and who, in the opinion of the investigator, would benefit from continued treatment as in their parent study but are unable to access this treatment outside of the clinical study."
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Myelogenous Leukemia",
                "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
            ],
            "keywords": [
                "Chronic Myelogenous Leukemia",
                "CML",
                "ALL",
                "CML-AP",
                "CML-BP",
                "CML-CP",
                "myeloproliferative neoplasm",
                "chronic phase",
                "accelerated phase",
                "blast phase",
                "ABL001",
                "asciminib"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 347,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Asciminib single agent group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with CML or ALL, from Novartis sponsored asciminib studies, including but not limited to CABL001A2301, CABL001A2302, CABL001X2101, CABL001A2202, CABL001AUS04 and CABL001AUS08 studies, that were receiving asciminib",
                    "interventionNames": [
                        "Drug: Asciminib single agent"
                    ]
                },
                {
                    "label": "Bosutinib single agent group",
                    "type": "OTHER",
                    "description": "Participants with CML-CP, from Novartis sponsored asciminib study CABL001A2301, that were receiving bosutinib",
                    "interventionNames": [
                        "Drug: Bosutinib"
                    ]
                },
                {
                    "label": "Bosutinib-Asciminib switch group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with CML-CP, from Novartis sponsored asciminib study CABL001A2301 that were receiving bosutinib treatment and switched to asciminib when entering this study or during the course of this study",
                    "interventionNames": [
                        "Drug: Asciminib single agent"
                    ]
                },
                {
                    "label": "Asciminib in combination with imatinib group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with CML from Novartis sponsored asciminib studies CABL001E2201 or CABL001X2101 that were receiving asciminib combined with imatinib",
                    "interventionNames": [
                        "Drug: Imatinib"
                    ]
                },
                {
                    "label": "Asciminib in combination with nilotinib group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with CML or ALL from Novartis sponsored asciminib studies CABL001E2201or CABL001X2101 that were receiving asciminib combined with nilotinib",
                    "interventionNames": [
                        "Drug: Nilotinib"
                    ]
                },
                {
                    "label": "Imatinib single agent group",
                    "type": "OTHER",
                    "description": "Participants with CML-CP, from Novartis sponsored asciminib study CABL001E2201 that were receiving imatinib",
                    "interventionNames": [
                        "Drug: Imatinib"
                    ]
                },
                {
                    "label": "Nilotinib single agent group",
                    "type": "OTHER",
                    "description": "Participants with CML-CP, from Novartis sponsored asciminib study CABL001E2201 and CABL001J12302 that were receiving nilotinib",
                    "interventionNames": [
                        "Drug: Nilotinib"
                    ]
                },
                {
                    "label": "Asciminib in combination with dasatinib group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with CML from Novartis sponsored study CABL001X2101 that were receiving asciminib with dasatinib",
                    "interventionNames": [
                        "Drug: Dasatinib"
                    ]
                },
                {
                    "label": "Dasatinib single agent group",
                    "type": "OTHER",
                    "description": "Participant with CML-CP , from Novartis sponsored asciminib study CABL001A2202, CABL001J12301, that were receiving Dasatinib.",
                    "interventionNames": [
                        "Drug: Dasatinib"
                    ]
                },
                {
                    "label": "Dasatinib-Asciminib switch group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with CML-CP, from Novartis sponsored asciminib study CABL001A2202 that were receiving best available therapy (dasatinib) and switched to asciminib when entering this study or during the course of this study",
                    "interventionNames": [
                        "Drug: Asciminib single agent"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Asciminib single agent",
                    "description": "Taken orally, twice daily (BID) or once daily (QD), in fasting state",
                    "armGroupLabels": [
                        "Asciminib single agent group",
                        "Bosutinib-Asciminib switch group",
                        "Dasatinib-Asciminib switch group"
                    ],
                    "otherNames": [
                        "ABL001"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Imatinib",
                    "description": "Taken orally, once daily, in the morning with low-fat meal",
                    "armGroupLabels": [
                        "Asciminib in combination with imatinib group",
                        "Imatinib single agent group"
                    ],
                    "otherNames": [
                        "STI571"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Nilotinib",
                    "description": "Taken orally, twice daily, on an empty stomach",
                    "armGroupLabels": [
                        "Asciminib in combination with nilotinib group",
                        "Nilotinib single agent group"
                    ],
                    "otherNames": [
                        "AMN107"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bosutinib",
                    "description": "Taken orally, once daily, with food",
                    "armGroupLabels": [
                        "Bosutinib single agent group"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Dasatinib",
                    "description": "Taken orally, once daily in a fasted state, 1 or 2 hours before a meal",
                    "armGroupLabels": [
                        "Asciminib in combination with dasatinib group",
                        "Dasatinib single agent group"
                    ],
                    "otherNames": [
                        "Sprycel"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with adverse events (AEs) and serious adverse events (SAEs)",
                    "description": "All AEs and SAEs will be tabulated and listed for participants in the Safety Set by treatment group. From day of first administration of study treatment to 30 days after the last study treatment.",
                    "timeFrame": "8 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of participants with clinical benefit as assessed by Investigator",
                    "description": "Investigators' assessment of clinical benefit will collected through the Investigator confirming that the patient is still benefiting from treatment. This will be evaluated and tabulated for participants in the Safety Set by treatment group at each visit.",
                    "timeFrame": "8 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n1. Participant with PH+ CML or PH+ ALL currently receiving treatment with asciminib (single agent or in combination with imatinib, nilotinib or dasatinib), imatinib, nilotinib or bosutinib alone within a Novartis-sponsored study and, in the opinion of the Investigator, would benefit from continued treatment.\n2. Participant has demonstrated compliance on the parent study protocol and is willing and able to comply with scheduled visits, treatment plans and any other study procedures.\n\nKey Exclusion Criteria:\n\n1. Participant has been discontinued from parent study treatment.\n2. Participant currently has unresolved toxicities reported as possibly related to study treatment in the parent study.\n3. Participant's ongoing treatment is currently approved and reimbursed at country level.\n4. Pregnant or nursing (lactating) women.\n5. Women of child-bearing potential, unless they are using highly effective methods of contraception and willing to continue while taking study treatment.\n6. Sexually active males receiving imatinib, nilotinib, bosutinib or dasatinib unwilling to follow the relevant contraception requirements in the local prescribing information.\n7. Applicable for participants on bosutinib treatment at the end of the CABL001A2301 and on other TKIs for CABL001A2202 study that switch to asciminib treatment:\n\n   * Asymptomatic (grade 2) pancreatitis if not resolved within 28 days\n   * QTcF\\>480msec or inability to determine QTc interval\n   * any grade 3 or 4 toxicity not resolved to grade 2 or lower within 28 days before starting asciminib treatment\n\nOther protocol-defined Inclusion/Exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Novartis Pharmaceuticals",
                    "role": "CONTACT",
                    "phone": "1-888-669-6682",
                    "email": "novartis.email@novartis.com"
                },
                {
                    "name": "Novartis Pharmaceuticals",
                    "role": "CONTACT",
                    "phone": "+41613241111"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Novartis Pharmaceuticals",
                    "affiliation": "Novartis Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Michigan Med University of Michigan .",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109 5271",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Moshe Talpaz",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10017",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dalisa Espinosa",
                            "role": "CONTACT",
                            "phone": "646-497-9068",
                            "email": "espinosD@mskcc.org"
                        },
                        {
                            "name": "Michael Mauro",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Oregon Health Sciences University .",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Uni of TX MD Anderson Cancer Cntr",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "713-792-2921"
                        },
                        {
                            "name": "Koji Sasaki",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Caba",
                    "state": "Buenos Aires",
                    "zip": "C1221ADC",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Wien",
                    "zip": "1140",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 48.20849,
                        "lon": 16.37208
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Rio de Janeiro",
                    "state": "RJ",
                    "zip": "20211-030",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -22.90278,
                        "lon": -43.2075
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Sao Paulo",
                    "state": "SP",
                    "zip": "05403 000",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Sao Paulo",
                    "state": "SP",
                    "zip": "08270-070",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Varna",
                    "zip": "9000",
                    "country": "Bulgaria",
                    "geoPoint": {
                        "lat": 43.21667,
                        "lon": 27.91667
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Montreal",
                    "state": "Quebec",
                    "zip": "H1T 2M4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Ostrava",
                    "state": "Poruba",
                    "zip": "708 52",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 49.83465,
                        "lon": 18.28204
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Brno-Bohunice",
                    "zip": "639 00",
                    "country": "Czechia"
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Copenhagen",
                    "zip": "DK-2100",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.67594,
                        "lon": 12.56553
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Bordeaux",
                    "zip": "33076",
                    "country": "France",
                    "geoPoint": {
                        "lat": 44.84044,
                        "lon": -0.5805
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "zip": "13273",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Paris 10",
                    "zip": "75475",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Vandoeuvre les Nancy",
                    "zip": "54511",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.65,
                        "lon": 6.18333
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "zip": "13353",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Frankfurt",
                    "zip": "60590",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.11552,
                        "lon": 8.68417
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Jena",
                    "zip": "07740",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.92878,
                        "lon": 11.5899
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "state": "MI",
                    "zip": "20162",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "state": "RM",
                    "zip": "00161",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80132",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Kobe-shi",
                    "zip": "650-0017",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.6913,
                        "lon": 135.183
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Uijeongbu si",
                    "state": "Gyeonggi Do",
                    "zip": "11759",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.7415,
                        "lon": 127.0474
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "COMPLETED",
                    "city": "Busan",
                    "zip": "49201",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 35.10278,
                        "lon": 129.04028
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "COMPLETED",
                    "city": "Jeollanam",
                    "zip": "519763",
                    "country": "Korea, Republic of"
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Beirut",
                    "zip": "1107 2020",
                    "country": "Lebanon",
                    "geoPoint": {
                        "lat": 33.88894,
                        "lon": 35.49442
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Monterrey",
                    "state": "Nuevo Leon",
                    "zip": "64460",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 25.67507,
                        "lon": -100.31847
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Krakow",
                    "zip": "30-688",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.06143,
                        "lon": 19.93658
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "zip": "02 776",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "COMPLETED",
                    "city": "Wroclaw",
                    "zip": "50 367",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 51.1,
                        "lon": 17.03333
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Lisboa",
                    "zip": "1099 023",
                    "country": "Portugal",
                    "geoPoint": {
                        "lat": 38.71667,
                        "lon": -9.13333
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Porto",
                    "zip": "4200-072",
                    "country": "Portugal",
                    "geoPoint": {
                        "lat": 41.14961,
                        "lon": -8.61099
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Timisoara",
                    "zip": "300079",
                    "country": "Romania",
                    "geoPoint": {
                        "lat": 45.75372,
                        "lon": 21.22571
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Moscow",
                    "zip": "125167",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Moscow",
                    "zip": "125284",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Saint Petersburg",
                    "zip": "197341",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "St Petersburg",
                    "zip": "191024",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Riyadh",
                    "zip": "11211",
                    "country": "Saudi Arabia",
                    "geoPoint": {
                        "lat": 24.68773,
                        "lon": 46.72185
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Singapore",
                    "zip": "169608",
                    "country": "Singapore",
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Sevilla",
                    "state": "Andalucia",
                    "zip": "41009",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "state": "Catalunya",
                    "zip": "08036",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hospitalet de LLobregat",
                    "state": "Catalunya",
                    "zip": "08907",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.35967,
                        "lon": 2.10028
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Bilbao",
                    "state": "Pais Vasco",
                    "zip": "48013",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 43.26271,
                        "lon": -2.92528
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28006",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28034",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46026",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Taoyuan",
                    "zip": "33305",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.95233,
                        "lon": 121.20193
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Samsun",
                    "zip": "55139",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.27976,
                        "lon": 36.3361
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Oxford",
                    "zip": "OX3 7LJ",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.75222,
                        "lon": -1.25596
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.\n\nThis trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com",
            "infoTypes": [
                "CSR"
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000007951",
                    "term": "Leukemia, Myeloid"
                },
                {
                    "id": "D000015464",
                    "term": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000009196",
                    "term": "Myeloproliferative Disorders"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18123",
                    "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
                    "asFound": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12149",
                    "name": "Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "asFound": "Myelogenous Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5033",
                    "name": "Blast Crisis",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "asFound": "Chronic",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1309",
                    "name": "Chronic Myeloid Leukemia",
                    "asFound": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1311",
                    "name": "Chronic Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "asFound": "Myelogenous Leukemia",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000068877",
                    "term": "Imatinib Mesylate"
                },
                {
                    "id": "D000069439",
                    "term": "Dasatinib"
                },
                {
                    "id": "C000498826",
                    "term": "Nilotinib"
                },
                {
                    "id": "C000471992",
                    "term": "Bosutinib"
                },
                {
                    "id": "C000621806",
                    "term": "Asciminib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000092004",
                    "term": "Tyrosine Kinase Inhibitors"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M81032",
                    "name": "Asciminib",
                    "asFound": "PVP",
                    "relevance": "HIGH"
                },
                {
                    "id": "M42200",
                    "name": "Bosutinib",
                    "asFound": "Perineal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M145649",
                    "name": "Nilotinib",
                    "asFound": "Rating",
                    "relevance": "HIGH"
                },
                {
                    "id": "M410",
                    "name": "Dasatinib",
                    "asFound": "Specified",
                    "relevance": "HIGH"
                },
                {
                    "id": "M324",
                    "name": "Imatinib Mesylate",
                    "asFound": "Record",
                    "relevance": "HIGH"
                },
                {
                    "id": "M239062",
                    "name": "Lactitol",
                    "relevance": "LOW"
                },
                {
                    "id": "M2889",
                    "name": "Tyrosine Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T22",
                    "name": "Tyrosine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}